- Home
- TKC vs ADMA Comparison
TKC vs ADMA Comparison
Compare TKC & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKC
- ADMA
- Stock Information
- Founded
- TKC 1993
- ADMA 2004
- Country
- TKC Turkey
- ADMA United States
- Employees
- TKC N/A
- ADMA N/A
- Industry
- TKC Telecommunications Equipment
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TKC Telecommunications
- ADMA Health Care
- Exchange
- TKC Nasdaq
- ADMA Nasdaq
- Market Cap
- TKC 5.6B
- ADMA 5.1B
- IPO Year
- TKC 2000
- ADMA N/A
- Fundamental
- Price
- TKC $6.07
- ADMA $19.84
- Analyst Decision
- TKC
- ADMA Strong Buy
- Analyst Count
- TKC 0
- ADMA 4
- Target Price
- TKC N/A
- ADMA $24.25
- AVG Volume (30 Days)
- TKC 850.5K
- ADMA 3.4M
- Earning Date
- TKC 05-09-2025
- ADMA 05-07-2025
- Dividend Yield
- TKC 3.93%
- ADMA N/A
- EPS Growth
- TKC 3.80
- ADMA N/A
- EPS
- TKC 0.28
- ADMA 0.84
- Revenue
- TKC $4,535,065,308.00
- ADMA $459,381,000.00
- Revenue This Year
- TKC $30.06
- ADMA $19.45
- Revenue Next Year
- TKC $30.03
- ADMA $28.10
- P/E Ratio
- TKC $8.70
- ADMA $23.74
- Revenue Growth
- TKC 2.83
- ADMA 62.23
- 52 Week Low
- TKC $5.66
- ADMA $9.40
- 52 Week High
- TKC $8.47
- ADMA $25.67
- Technical
- Relative Strength Index (RSI)
- TKC 43.60
- ADMA 45.08
- Support Level
- TKC $6.22
- ADMA $18.95
- Resistance Level
- TKC $6.51
- ADMA $20.14
- Average True Range (ATR)
- TKC 0.11
- ADMA 0.78
- MACD
- TKC -0.01
- ADMA -0.13
- Stochastic Oscillator
- TKC 26.67
- ADMA 47.59
About TKC Turkcell Iletisim Hizmetleri AS
Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes high-quality mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, the Netherlands, and Ukraine. It has three main reportable segments: Turkcell Turkiye, Turkcell International, and Techfin. The Turkcell Turkiye segment, which derives the majority of revenue, comprises mainly telecommunication and technology services activities.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.